Saltiel AR. Insulin signaling in health and disease. J Clin Invest. 2021;131(1):e142241.
Article CAS PubMed PubMed Central Google Scholar
Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance. Physiol Rev. 2018;98(4):2133–223.
Article CAS PubMed PubMed Central Google Scholar
Bedinger DH, Adams SH. Metabolic, anabolic, and mitogenic insulin responses: a tissue-specific perspective for insulin receptor activators. Mol Cell Endocrinol. 2015;415:143–56.
Article CAS PubMed Google Scholar
Xu J, Cai S, Zhao J, Xu K, Ji H, Wu C, Xiao J, Wu Y. Advances in the relationship between pyroptosis and diabetic neuropathy. Front Cell Dev Biol. 2021;9:753660.
Article PubMed PubMed Central Google Scholar
Golubnitschaja O, Baban B, Boniolo G, Wang W, Bubnov R, Kapalla M, Krapfenbauer K, Mozaffari MS, Costigliola V. Medicine in the early twenty-first century: paradigm and anticipation - EPMA position paper 2016. EPMA J. 2016;7(1):23.
Article PubMed PubMed Central Google Scholar
Golubnitschaja O, Costigliola V, Epma. General report & recommendations in predictive, preventive and personalised medicine 2012: white paper of the European Association for Predictive Preventive and Personalised Medicine. EPMA J. 2012;3(1):14.
Article PubMed PubMed Central Google Scholar
Golubnitschaja O, Watson ID, Topic E, Sandberg S, Ferrari M, Costigliola V. Position paper of the EPMA and EFLM: a global vision of the consolidated promotion of an integrative medical approach to advance health care. EPMA J. 2013;4(1):12.
Article PubMed PubMed Central Google Scholar
Mazumdar D, Singh S. Diabetic encephalopathy: role of oxidative and nitrosative factors in type 2 diabetes. Indian J Clin Biochem. 2024;39(1):3–17.
Article CAS PubMed Google Scholar
Zhang D, Jiang S, Meng H. Role of the insulin-like growth factor type 1 receptor in the pathogenesis of diabetic encephalopathy. Int J Endocrinol. 2015;2015:626019.
Article PubMed PubMed Central Google Scholar
Schemmel KE, Padiyara RS, D’Souza JJ. Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review. J Diabetes Complications. 2010;24(5):354–60.
Li J, Xu S, Wang L, Wang X. PHPB attenuated cognitive impairment in type 2 diabetic KK-Ay mice by modulating SIRT1/insulin signaling pathway and inhibiting generation of AGEs. Pharmaceuticals (Basel). 2023;16(2):305.
Article CAS PubMed Google Scholar
Nagayach A, Bhaskar R, Ghosh S, Singh KK, Han SS, Sinha JK. Advancing the understanding of diabetic encephalopathy through unravelling pathogenesis and exploring future treatment perspectives. Ageing Res Rev. 2024;100:102450.
Article CAS PubMed Google Scholar
Safe S, Abdelrahim M. Sp transcription factor family and its role in cancer. Eur J Cancer. 2005;41(16):2438–48.
Article CAS PubMed Google Scholar
Chu S. Transcriptional regulation by post-transcriptional modification–role of phosphorylation in Sp1 transcriptional activity. Gene. 2012;508(1):1–8.
Article CAS PubMed Google Scholar
Xie J, Yin H, Nichols TD, Yoder JA, Horowitz JM. Sp2 is a maternally inherited transcription factor required for embryonic development. J Biol Chem. 2010;285(6):4153–64.
Article CAS PubMed Google Scholar
Kingsley C, Winoto A. Cloning of GT box-binding proteins: a novel Sp1 multigene family regulating T-cell receptor gene expression. Mol Cell Biol. 1992;12(10):4251–61.
CAS PubMed PubMed Central Google Scholar
Ratajewski M, Walczak-Drzewiecka A, Gorzkiewicz M, Sałkowska A, Dastych J. Expression of human gene coding RORγT receptor depends on the Sp2 transcription factor. J Leukoc Biol. 2016;100(5):1213–23.
Article CAS PubMed Google Scholar
Zhao LY, Yao Y, Han J, Yang J, Wang XF, Tong DD, Song TS, Huang C, Shao Y. miR-638 suppresses cell proliferation in gastric cancer by targeting Sp2. Dig Dis Sci. 2014;59(8):1743–53.
Article CAS PubMed Google Scholar
Baumgart S, Chen NM, Zhang JS, Billadeau DD, Gaisina IN, Kozikowski AP, Singh SK, Fink D, Ströbel P, Klindt C, Zhang L, Bamlet WR, Koenig A, Hessmann E, Gress TM, Ellenrieder V, Neesse A. GSK-3β Governs inflammation-induced NFATc2 signaling hubs to promote pancreatic cancer progression. Mol Cancer Ther. 2016;15(3):491–502.
Article CAS PubMed PubMed Central Google Scholar
Zhu Y, Cui J, Liu J, Hua W, Wei W, Sun G. Sp2 promotes invasion and metastasis of hepatocellular carcinoma by targeting TRIB3 protein. Cancer Med. 2020;9(10):3592–603.
Article CAS PubMed PubMed Central Google Scholar
Phan D, Cheng CJ, Galfione M, Vakar-Lopez F, Tunstead J, Thompson NE, Burgess RR, Najjar SM, Yu-Lee LY, Lin SH. Identification of Sp2 as a transcriptional repressor of carcinoembryonic antigen-related cell adhesion molecule 1 in tumorigenesis. Cancer Res. 2004;64(9):3072–8.
Article CAS PubMed Google Scholar
Terrados G, Finkernagel F, Stielow B, Sadic D, Neubert J, Herdt O, Krause M, Scharfe M, Jarek M, Suske G. Genome-wide localization and expression profiling establish Sp2 as a sequence-specific transcription factor regulating vitally important genes. Nucleic Acids Res. 2012;40(16):7844–57.
Article CAS PubMed PubMed Central Google Scholar
Baur F, Nau K, Sadic D, Allweiss L, Elsässer HP, Gillemans N, de Wit T, Krüger I, Vollmer M, Philipsen S, Suske G. Specificity protein 2 (Sp2) is essential for mouse development and autonomous proliferation of mouse embryonic fibroblasts. PLoS One. 2010;5(3):e9587.
Article PubMed PubMed Central Google Scholar
Da CM, Liao HY, Deng YS, Zhao GH, Ma L, Zhang HH. Transcription factor SP2 regulates ski-mediated astrocyte proliferation in vitro. Neuroscience. 2021;479:22–34.
Article CAS PubMed Google Scholar
Allenby MC, Woodruff MA. Image analyses for engineering advanced tissue biomanufacturing processes. Biomaterials. 2022;284:121514.
Article CAS PubMed Google Scholar
Lu T, Yang B, Wang R, Qin C. Xenotransplantation: current status in preclinical research. Front Immunol. 2019;10:3060.
Article CAS PubMed Google Scholar
Nithin R, Aggarwal A, Sravani AB, Mallya P, Lewis S. Organ-on-a-chip: an emerging research platform. Organogenesis. 2023;19(1):2278236.
Maqsood MI, Matin MM, Bahrami AR, Ghasroldasht MM. Immortality of cell lines: challenges and advantages of establishment. Cell Biol Int. 2013;37(10):1038–45.
Saeidnia S, Manayi A, Abdollahi M. From in vitro experiments to in vivo and clinical studies; pros and cons. Curr Drug Discov Technol. 2015;12(4):218–24.
Article CAS PubMed Google Scholar
Zeng X, Zhang Y, Kwong JS, Zhang C, Li S, Sun F, Niu Y, Du L. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med. 2015;8(1):2–10.
Hoyer S. Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis. J Neural Transm (Vienna). 1998;105(4–5):415–22.
Comments (0)